Barclays

The Singapore government’s investment arm Temasek Holdings ventured into the euro-denominated bond market for the first time this week with a dual tranche offering driven by reverse enquiry.

Any fears that investors might be nervous about sterling bonds in the run-up to the UK’s referendum on European Union membership eased with a pair of deals on Tuesday.

NL Financial Investments, the Dutch state agency, has named bookrunners for the IPO of insurer ASR, having already chosen the global co-ordinators earlier this year.

Mark Bamford, head of global fixed income syndicate, is leaving the firm, and several promotions have been made to fill the gap. Fixed income syndicate has also been transferred out of fixed income and given its own risk reporting.

India’s National Thermal Power Corp (NTPC) ended an absence of more than a year from the international bond market this week with a tightly priced transaction that left little money on the table for investors.

A plunge in sterling’s value on Monday after the UK government picked a date for the country’s European Union membership is unlikely to stop SSAs adding to a record breaking year in the currency so far, said bankers.

Cheung Kong Infrastructure Holdings (CKI) is on track for a comeback to the dollar hybrid bond market, while India’s National Thermal Power Corp kicked off bookbuilding for a 10 year Reg S offering on Monday.

Like the film of the same name, investment bank 'matrix' structures make GlobalCapital’s head hurt, and become tedious when they’re repeated a few times. Trying to decipher which banker is responsible for which business becomes a complex head-scratcher. One imagines revenue-credit discussions are similarly painful.

Thames Water priced a £300m senior secured no-grow bond on Thursday, clinching the deal after two weeks of volatility in its outstanding bonds.

Macquarie issued its inaugural covered bond on Thursday, meeting a strong reception with the five year €500m paper twice subscribed by investors. Westpac has also opened books on a $1.35bn deal, as Fitch said it expects Australian covered bond issuance to rise this year.

US biotechnology company Amgen made its dash into primary corporate bond markets on Thursday with a dual tranche deal that took €2bn out of the market.

Marcel Koebeli, the country head of Switzerland at Barclays, has left the bank.